Effectiveness, safety and cost analysis of dalbavancin in clinical practice

Spanish observational study of 102 patients treated with dalbavancin found that treatment was off-label in 70% of cases and generally used to facilitate discharge. Use was found to be safe and was predicted to have saved 4550 Euros owing to reduced hospital stays.

European Heart Journal